T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding

被引:9
作者
Dewitz, Christin [1 ]
Moeller-Hackbarth, Katja [1 ]
Schweigert, Olga [1 ]
Reiss, Karina [2 ]
Chalaris, Athena [1 ]
Scheller, Juergen [3 ]
Rose-John, Stefan [1 ]
机构
[1] Univ Kiel, Inst Biochem, Fac Med, Kiel, Germany
[2] Univ Kiel, Dept Dermatol, Kiel, Germany
[3] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany
关键词
ADAM10; calmodulin; ferritin; shedding; T-cell immunoglobulin and mucin domain2; SOLUBLE INTERLEUKIN-6 RECEPTOR; IL-6; RECEPTOR; L-SELECTIN; FACTOR-ALPHA; H-FERRITIN; ADAM10; PROTEIN; DISINTEGRIN; CLEAVAGE; ADHESION;
D O I
10.1111/febs.12583
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T-cell immunoglobulin and mucin domain (TIM)-2 is expressed on activated Bcells. Here, we provide evidence that murine TIM-2 is a target of ADAM10-mediated ectodomain shedding, resulting in the generation of a soluble form of TIM-2. We identified ADAM10 but not ADAM17 as the major sheddase of TIM-2, as shown by pharmacological ADAM10 inhibition and with ADAM10-deficient and ADAM17-deficient murine embryonic fibroblasts. Ionomycin-induced or 2(3)-O-(4-benzoylbenzoyl) ATP triethylammonium salt-induced shedding of TIM-2 was abrogated by deletion of 10 juxtamembrane amino acids from the stalk region but not by deletion of two further N-terminally located blocks of 10 amino acids, indicating a membrane-proximal cleavage site. TIM-2 lacking the intracellular domain was cleaved after ionomycin or 2 (3)-O-(4-benzoylbenzoyl) ATP triethylammonium salt treatment, indicating that this domain was not involved in the regulation of ectodomain shedding. Moreover, TIM-2 shedding was negatively controlled by calmodulin. Shed and soluble TIM-2 interacted with H-ferritin. In summary, we describe TIM-2 as a novel target for ADAM10-mediated ectodomain shedding, and reveal the involvement of ADAM proteases in cellular iron homeostasis.
引用
收藏
页码:157 / 174
页数:18
相关论文
共 50 条
[31]   The role of polymorphism of interleukin-2,-10,-13 and TNF-α genes in cutaneous T-cell lymphoma pathogenesis [J].
Nedoszytko, Boguslaw ;
Olszewska, Berenika ;
Roszkiewicz, Jadwiga ;
Glen, Jolanta ;
Zablotna, Monika ;
Lugowska-Umer, Hanna ;
Nowicki, Roman ;
Sokolowska-Wojdylo, Malgorzata .
POSTEPY DERMATOLOGII I ALERGOLOGII, 2016, 33 (06) :429-434
[32]   KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma [J].
Decroos, Amandine ;
Cheminant, Morgane ;
Bruneau, Julie ;
Carras, Sylvain ;
Parinet, Vincent ;
Pelletier, Laura ;
Lacroix, Laetitia ;
Martin, Nadine ;
Giustiniani, Jerome ;
Lhermitte, Ludovic ;
Asnafi, Vahid ;
Battistella, Maxime ;
Lemonnier, Francois ;
de Leval, Laurence ;
Sicard, Helene ;
Bonnafous, Cecile ;
Gauthier, Laurent ;
Genestier, Laurent ;
Caruso, Stefano ;
Gaulard, Philippe ;
Hermine, Olivier ;
Ortonne, Nicolas .
HAEMATOLOGICA, 2023, 108 (10) :2830-2836
[33]   IL-10 suppresses CD2-mediated T cell activation via SHP-1 [J].
Taylor, Alison ;
Verhagen, Johan ;
Akkoc, Tunc ;
Wenig, Renate ;
Flory, Egbert ;
Blaser, Kurt ;
Akdis, Muebeccel ;
Akdisa, Cezrni A. .
MOLECULAR IMMUNOLOGY, 2009, 46 (04) :622-629
[34]   Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation [J].
Gross, Catharina C. ;
Schulte-Mecklenbeck, Andreas ;
Ruenzi, Anna ;
Kuhlmann, Tanja ;
Posevitz-Fejfar, Anita ;
Schwab, Nicholas ;
Schneider-Hohendorf, Tilman ;
Herich, Sebastian ;
Held, Kathrin ;
Konjevic, Matea ;
Hartwig, Marvin ;
Dornmair, Klaus ;
Hohlfeld, Reinhard ;
Ziemssen, Tjalf ;
Klotz, Luisa ;
Meuth, Sven G. ;
Wiendl, Heinz .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (21) :E2973-E2982
[35]   Augmentation of T-cell immune responses and signal transduction proteins in oral cancer patients: potential for IL-2-mediated immunotherapy [J].
Cheriyan, Vino T. ;
Thomas, Cessal ;
Balaram, Prabha .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) :1435-1444
[36]   Dimerization of Soluble HLA-G by IgG-Fc Fragment Augments ILT2-Mediated Inhibition of T-Cell Alloresponse [J].
Zhang, Maohua ;
Weng, Xiufang ;
Liang, Zhihui ;
Lu, Shengjun ;
Li, Jianan ;
Chen, Xueling ;
Li, Qing ;
Sun, Wei ;
Song, Yinhong ;
Shen, Guanxin ;
Wu, Xiongwen .
TRANSPLANTATION, 2009, 87 (01) :8-15
[37]   NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells [J].
Ibanez-Navarro, Marta ;
Fernandez, Adrian ;
Escudero, Adela ;
Esteso, Gloria ;
Campos-Silva, Carmen ;
Navarro-Aguadero, Miguel Angel ;
Leivas, Alejandra ;
Caracuel, Beatriz Ruz ;
Rodriguez-Antolin, Carlos ;
Ortiz, Alejandra ;
Navarro-Zapata, Alfonso ;
Mestre-Duran, Carmen ;
Izquierdo, Manuel ;
Balaguer-Perez, Maria ;
Ferreras, Cristina ;
Martinez-Lopez, Joaquin ;
Vales-Gomez, Mar ;
Perez-Martinez, Antonio ;
Fernandez, Lucia .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[38]   DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells [J].
Bhopale, Mahendra K. ;
Hilliard, Brendan ;
Constantinescu, Cris. S. ;
Fujioka, Toshiki ;
Ventura, Elvira ;
Phillips, S. Michael ;
Rostami, Abdolmohamad .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 96 (01) :108-117
[39]   TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy [J].
Amiset, Laurent ;
Fend, Laetitia ;
Gatard-Scheikl, Tania ;
Rittner, Karola ;
Duong, Vanessa ;
Rooke, Ronald ;
Muller, Sylviane ;
Bonnefoy, Jean-Yves ;
Preville, Xavier ;
Haegel, Helene .
ONCOIMMUNOLOGY, 2012, 1 (08) :1271-1280
[40]   A Bispecific gd T-cell Engager Targeting EGFR Activates a Potent Vg9Vd2 T cell-Mediated Immune Response against EGFR-Expressing Tumors [J].
King, Lisa A. ;
Toffoli, Elisa C. ;
Veth, Myrthe ;
Iglesias-Guimarais, Victoria ;
Slot, Manon C. ;
Amsen, Derk ;
van de Ven, Rieneke ;
Derks, Sarah ;
Fransen, Marieke F. ;
Tuynman, Jurriaan B. ;
Riedl, Thilo ;
Roovers, Rob C. ;
Adang, Anton E. P. ;
Ruben, Jurjen M. ;
Parren, Paul W. H. I. ;
de Gruijl, Tanja D. ;
van der Vliet, Hans J. .
CANCER IMMUNOLOGY RESEARCH, 2023, 11 (09) :1237-1252